Reactive oxygen species (ROS) are emerging as centre-stage players in cardiac functional regulation. ROS and Ca 2+ signals converge at dyads, the structural and functional units of cardiac excitation-contraction coupling. These two prominent signalling systems are intertwined with ROS modulation of the entire Ca 2+ -signalling network, and vice versa. While constitutively generated homoeostatic ROS are important in setting the redox potential of the intracellular milieu, dynamic signalling ROS shape microdomain and global Ca 2+ signals on both the beat-to-beat and greater time scales. However, ROS effects are complex and subtle, characterized by multiphasic and bidirectional Ca 2+ responses; and sustained oxidative stress may lead to compromised contractility and arrhythmogenicity. These new understandings should be leveraged to harness ROS for their beneficial roles while avoiding deleterious effects in the heart.
Introduction
Reactive oxygen species (ROS) are a group of chemical species that comprise at least one oxygen atom in each molecule but display stronger reactivity than molecular oxygen. ROS are classified into two categories: free radicals with an unpaired electron (e.g. O 2 †2 and OH † ) and non-radical derivatives (e.g. H 2 O 2 ). Closely related, the principal reactive nitrogen species (RNS) is † NO, a free radical that plays a central role in cardiovascular signalling. Basal, homoeostatic ROS are required to set the redox balance of the cell; when ROS are produced excessively or antioxidant capacity is depleted, indiscriminate oxidation of proteins, lipids, and polynucleotides elicits harmful effects, causing 'oxidative stress'. The most exciting ongoing development, however, is that ROS and RNS emerge as welcome additions to the repertoire of only a handful of known second messengers (Ca 2+ , cAMP, IP 3 , arachidonic acid). That is, dynamic, regulatory and often compartmentalized increases of ROS and RNS are harnessed as powerful, ubiquitous, and indispensable cellular messengers-redox signalling-which is defined as the specific, usually reversible oxidative/reductive modification of cellular signalling pathway components. 1 The ROS/RNS-specific targets range from ion channels and transporters to kinases and phosphatases and to transcription factors, and the list continues to grow and permeate throughout pivotal pathways in differentiation and organogenesis, 2 cell fate regulation, 3 stress responses, 4 and wound-healing. 5, 6 Chemically a single-atom divalent cation, the calcium ion (Ca  2+ ) acts as the most important biological messenger known. In the mammalian heart, meeting the stringent functional demands apparently hinges on a rather unique microscopic structure, the dyad. On one hand, the sarcolemma forms invaginations or transverse tubules (TTs) 180 -280 nm in diameter along the Z-lines of sarcomeres, at longitudinal intervals of 1.8 mm and circumferential intervals of 0.5 -1.5 mm.
9,10 The TTs traverse the entire cell interior while interconnecting with each other. Thus, the surface sarcolemma and TTs constitute one physically continuous membrane system, providing an electrical highway for the rapid spread of the action potential throughout the bulk of the cardiomyocyte, at a velocity too fast to be detected with the 1.5-ms resolution of confocal linescan microscopy, 11 for the electrical synchrony of the heart at the cellular level. at the dyads ( Figure 1) . A highly energy-demanding cell type, the cardiomyocyte contains 6000 mitochondria that occupy 30 -40% of the cell volume.
Importantly, mitochondria are present in close proximity (40 -180 nm) to TT-SR dyads, 15 and form junctional contacts or even tether with the jSR. 16 -18 While supplying local ATP on demand, they are also the major source of local ROS production and play significant roles in local Ca 2+ handling (see below). In an extended view, trios of dyadic TT-SR and their associated mitochondria are recognized as the main structural, functional, and regulatory units of microdomain Ca 2+ and ROS signalling in the heart (Figure 1 ). into H 2 O 2 and catalases convert H 2 O 2 to water. The non-enzymatic antioxidants include glutathione, peroxiredoxin, thioredoxin, and NADPH. They collectively form an antioxidant pool, with associated enzymes such as glutathione peroxidase and thioredoxin reductase that promote inter-conversion towards an equilibrium between the reduced/oxidized species and among different antioxidants. 31 -35 Under experimental conditions, exogenous ROS scavengers may also be present, such as the SOD mimic MnTyP 36 and the mitochondrial-targeted antioxidants, mitoTEMPO, 37 and the synthetic tetrapeptide SS31. 38 Local ROS gradients and thus the distance of action are collectively determined not only by the flux, the lifetime, and the compartmentalization of the ROS of interest, but also by the local ROS-scavenging capacity which is in part determined by the redox status of the antioxidant pool.
Microdomain

Constitutive mitochondrial ROS production
The mitochondrial respiratory chain efficiently transfer electrons along intermolecular and intramolecular pathways of increasing redox potential (E h ), from E h ¼ 2320 mV at the entry point of Complex I (NADH dehydrogenase), all the way to E h ¼ +390 mV at Complex IV (cytochrome c oxidase), where four electrons are donated to O 2 forming two molecules of H 2 O. However, with its E h ¼ 2160 mV, O 2 also snaps up 0.15-2% of the respiratory chain electrons, one at a time, at places prior to Complex IV, and undergoes one-electron reduction to form O 2 †2 . 39, 40 There are two major respiratory chain complexes in the mitochondria which produce ROS: Complex I and Complex III (ubiquinol cytochrome c reductase). 41 The O 2 †2 formation occurs in the mitochondrial matrix (Complexes I and II) and on both sides of the inner mitochondrial membrane (Complex III). 32 This mode of ROS production is obligatorily linked to mitochondrial respiration, and appears to be constitutive, continuous, and relatively constant. Mitochondrial O 2 †2 is quickly converted to H 2 O 2 by SOD2 abundantly present in the matrix and cytochrome c in the intermembrane space. 42 In addition, monoamine oxidases (MAOs) on the outer mitochondrial membrane also generate H 2 O 2 as they catalyse the breakdown of neurotransmitters such as catecholamines. Mechanistically, superoxide flashes are triggered by the opening of a physiologically relevant mitochondrial permeability transition pore (mPTP), 43, 44 and each coincides with an electrophysiological excitation of the mitochondrion, i.e. depolarization of mitochondrial membrane potential (C m ). Careful analysis of flash ignition suggested that it is a regenerative process dominated by the stochastic recruitment of a limited number of participating units (e.g. mPTPs). 45 Surprisingly, superoxide flashes are abolished by all electron transfer chain (ETC) blockers tested, including antimycin A that actually enhances constitutive mitochondrial ROS production. 43 Albeit paradoxical, this result has been reproduced in different laboratories, 46, 47 and it is in general agreement with the notion that signalling ROS and homoeostatic ROS are regulated by distinctly different mechanisms. To date, the exact mechanisms underlying superoxide flash formation and termination remain open questions. Increasing evidence supports the notion that superoxide flashes constitute elemental local ROS signalling events in physiological, stressful, and pathophysiological conditions. 48 They are richly regulated in a frequency-modulated manner, by diverse signals converging onto the ETC and mPTP. As is the case for Ca 2+ sparks, superoxide flash modulation occurs predominantly in a frequency-modulated manner, with only minor-to-moderate changes in the amplitude and duration. This 'digital' feature of ROS signalling bears a close resemblance to that of cardiac Ca 2+ signalling depicted above, which is crucial to achieving signalling efficiency, specificity, and stability. Functionally, superoxide flash activity in skeletal muscle decodes the status of cellular and mitochondrial energy metabolism both in vivo and in vitro, 44, 46, 47, 49 and is elevated in the skeletal muscle of RyR1 Y522S/ WT malignant hyperthermic mice which exhibit marked temperaturedependent increases in ROS and RNS generation. 46 It also responds to oxidative stress induced by hypoxia-and anoxia-reoxygenation in cardiomyocytes. 43, 50 In HeLa cells with elevated mitochondrial basal ROS production and Ca 2+ uniporter activity, flash activity displays a reversible 20-fold increase that contributes to the activation of JNK and p38, essential signals for adaptive cell-survival responses. 51 In addition, superoxide flashes are involved in numerous biological and pathological process, such as cortical neural progenitor proliferation and cerebral cortical development, 52 Huntington's disease, 53 and cancer cell apoptosis. 54 It is noteworthy that, owing to their low frequency, brief duration and spatial confinement, superoxide flashes make only a negligible contribution to global ROS homoeostasis, 52, 54 unless at very high frequencies (Wei-LaPierre et al., personal communication).
Mitochondrial superoxide flashes
ROS-induced ROS release
While superoxide flashes do not normally propagate, intermitochondrial ROS-induced ROS release (RIRR) occurs under extreme stress conditions. Zorov et al. 55, 56 have shown that intense photostimulation-elicited ROS triggers mPTP openings that cause mitochondrial ROS bursts. Unlike superoxide flashes of the physiologically relevant mPTP, photostimulated RIRR is likely triggered by peroxide and singlet oxygen ( 1 O 2 ) from photon-induced triplet state fluorochromes, and occurs within a narrow time-window prior to permanent cell injury, somewhat analogous to the mPTP opening at the commitment to cell death. 57, 58 The O'Rourke group found that local laser flash-induced mPTP-dependent ROS can trigger selfsustained oscillations in DC m and ROS in cardiomyocytes. 59, 60 The whole-cell oscillations depend on the mitochondrial inner membrane anion channels rather than the mPTP. 59, 60 Using this protocol, our own study also revealed a spectrum of ROS signals, from local mitochondrial ROS bursts, to self-sustaining cell-wide ROS oscillations, and to ROS waves that propagate at a velocity of 4 mm/s. 61 To extend the spark-flash analogy, global ROS oscillations and waves may consist of superoxide flashes as elemental events; however, the transition from discrete solitary events to RIRR may require the ROS system to be poised beyond a 'criticality' permissive for regenerative ROS production. 62, 63 Moreover, the criticality more likely reflects the ROS excitability of the mitochondrial network, rather than the magnitude of the trigger ROS, for we failed to observe propagating ROS waves during synchronous superoxide flashes involving extensive perinuclear mitochondrial networks of .100 mm 3 .
64
It should be noted that the mitochondria can directly access the Ca 2+ microdomains at their associated dyads. The ruthenium red- 
ROS generation by NADPH oxidase: X-ROS
NADPH oxidases and the related dual oxidase (Duox) family has seven members, Nox1, Nox2, Nox3, Nox4, Nox5, Duox1, and Duox2, but only the Nox2, Nox1, and Nox4 isoforms are expressed in the heart, Nox2 being the predominant isoform in the adult cardiomyocyte. 71 Nox2 is localized in the TTs of cardiac and skeletal muscles, 72, 73 making it an important player at the dyads. Similarly, eNOS is preferentially localized at the caveolae in TTs and the surface sarcolemma 74, 75 while nNOS is localized not only at the caveolae 76,77 but also at the SR membrane (Figure 1) . 78 In 72 have shown that a stepwise stretch of cardiomyocyte produces a 10-s long ROS transient that derives from Nox2, named 'X-ROS', and this response is sensitive to Nox inhibitors and absent in Nox2 2/2 cardiomyocytes.
Remarkably, this X-ROS transient rises immediately upon stretch, making it suitable for beat-to-beat mechanochemical transduction. 72, 79 In an earlier related study, however, the Sollott group has demonstrated that stretch-activated, L-NAME-sensitive † NO production can be detected by 4,5-diaminofluorescein fluorescence at 10 min after a single-step static 10% stretch. These data show differential temporal dynamics of ROS and RNS signalling at the dyads. With the advent of the new cell-stretch technique, 80 it would be of interest to determine how X-ROS respond to cyclic stretch in beating cardiomyocytes and even beating hearts and to further characterize the differential dynamics of X-ROS and RNS signalling at the dyads. 90 A stretch activation of the eNOS-Akt-PI3K pathway has been suggested to underlie these responses. 90 As is the case with stretch-activated RNS but in contrast to the phasic and bidirectional effects of ROS and X-ROS, exogenous RNS effects appear to be excitatory and more enduring in general. For instance, S-nitroso-N-acetylpenicillamine, tissue generates two acoustic waves with different properties, the P-wave, which is compressional or tensile and the S-wave which is a shear wave. The former propagates at 1550 m/s and the latter at 1-5 m/s ( 2 m/s in skeletal muscle). 92 It is clear that the P-wave (i.e. the stretch caused by preload in a cardiac cycle) traverses the entire myocardium in a fraction of a millisecond, faster than the propagation of action potentials ( 1.5 m/s in the bundle of His). Assuming the X-ROS mechanism operates in the intact heart, the mechanical stretch precedes waves of electrical excitation, and triggers instantaneous X-ROS production so to prime the myocardium by sensitizing the CICR mechanism, for stronger contraction when excited. In this regard, the newly described stretch-activated NOX2-dependent ROS (X-ROS) may provide a mechanism for the 'biomechanical synchrony' of the heart, to ensure homogenous force development and workload partition on a beat-to-beat basis. The Frank -Starling law of the heart states that increasing enddiastolic pressure (hence stretch of the myocardium) induces a more powerful peak systolic pressure (hence a more powerful contraction) (Figure 2) . A large component of the stretch/length dependence has been attributed to the rearrangement of contractile filaments and the enhancement of their Ca 2+ sensitivity. 93 However, it is conceivable that X-ROS-enhanced local Ca 2+ signalling also makes a significant contribution, provided that it outweighs the direct inhibitory effects of ROS on myofilament contractility.
ROS regulation of microdomain
72,79
When compared with the X-ROS, RNS might be a slowly developing signal, because the immediate Ca 2+ spark response (within 10 s) is insensitive to the inhibition of NOS by L-NAME. Thus, RNS appear to have little to do with the hypothetical biomechanical synchrony. Nevertheless, they are enduring signals, and exert a greater effect on Ca 2+ sparks ( 400 vs. 30% increases in the Ca 2+ spark rate at 10% stretch, for X-ROS and RNS, respectively). 90 
ROS Regulation of RyR: a complex story
The cardiac RyR is a homotetramer with each subunit containing 21 free cysteine residues, 96 amounting to 84 thiols in a channel, and 8000 in a Ca 2+ release unit . Some of the hyperactive SH groups on the RyR appear to have a redox-sensing function, conferring on it the ability to act as a redox sensor. 97 -100 The oxidation of critical SH bonds within the RyR complex is responsible for opening the channel pore. 101 In purified cardiac RyR channels incorporated into planar lipid bilayers, H 2 O 2 increases the channel open probability and this effect is reversed by the SH-reducing agent dithiothreitol (DTT). 102 Similarly, OH † and SH-oxidizing reagents react with some SH groups of the RyR and increase the open probability of the channel. 103 Reagents that specifically oxidize free-SH groups and promote the formation of disulfide bonds within the RyR complex, such as 2,2 ′ -dithiodipyridine, activate the RyR, and this effect is reversed by reagents that reduce disulfides to thiols (e.g. DTT and glutathione). 104 Given the diversity of ROS species and ROS effector proteins and the promiscuity of the ROS-reactive sites on the RyR, it can be understood that the regulation of Ca 2+ sparks by ROS can be both stimulatory and inhibitory, depending on the dose, the history and duration, and the cellular context. In particular, the aforementioned 'mode-switch' response differs from conventional channel inactivation or 'adaptation'. Instead, it may be accounted for by a simple four-state hypothetical model in which the RyR contains two ROS-reactive sites of different kinetics and affinity ( Figure 3) . Oxidation of the fast but low-affinity site alone increases the channel open probability, while oxidation of the slow but the high-affinity site is functionally neutral by itself but brings the channel to a state such that subsequent oxidative modification negatively regulates the channel activity, manifesting as a modality switch. This model resembles the model of Abramson and Salama 101 with one fundamental difference. Their model for redox modification of the RyR involves three sulfhydryl groups in close proximity: thiol oxidation that forms a disulfide bond opens the channel, and subsequent thiol-disulfide interchange closes the channel. Our model, however, hypothesizes that a slow ROS modification primes the channel to render the opposite response to subsequent ROS modification ( Figure 3) . Experimental testing of these models would provide new insights into the complexity and subtlety of ROS regulation of effector proteins in general and RyR in particular.
Pathological relevance
While clinical interventions with antioxidants have thus far proven to have little or no impact on cardiac disease risk and progression, 109 -111 this failure may stem in part from the fact that a complete picture of ROS involvement in heart diseases is still lacking. On the other hand, increasing evidence shows that the redox state of the failing heart is altered towards greater oxidation which directly or indirectly affects Ca 2+ handling. The antioxidant defence, such as SOD and thioredoxin, is decreased in heart failure (HF); 112 129 The depressed SR Ca 2+ load depends not only on RyR hyperactivity, but also on SERCA oxidation, which tends to inhibit its activity 130 (see also 91 for RNS enhancement of pump activity).
The fact that these defects are partly normalized by reducing agents 129, 131, 132 points to the importance of RyR oxidation in HF.
Clinical data have also shown that inhibition of xanthine oxidase in HF patients ameliorates the ejection fraction after 1 month of treatment. 133 Taken together, these data strongly suggests that ROS are culprits driving the disease progression in HF. 135 has also been linked to pro-arrhythmogenic Ca 2+ waves. Intriguingly, the ROS mechanism seems to be intertwined with the classic phosphorylation mechanism of post-translational modification of the RyR. The effect of RyR oxidation is synergistically enhanced by its PKA-and CaMKIIdependent phosphorylation, because both kinases are activated by elevated oxidation 136 and both contribute to the RyR leak in cardiomyopathy. 23, 137 In a dog model of sudden death, ROS-mediated oxidation of RyR is involved in arrhythmogenic Ca 2+ alternans by increasing the fractional SR release, RyR sensitivity to Ca 2+ and diastolic leak, defects that are normalized by reducing agents. 138 Arrhythmogenic early after depolarizations may also be activated by oxidation, acting either directly on the LTCC 139 or though CaMKII activation, which enhances Ca 2+ entry through LTCC. 140 -142 Besides oxidizing RyR and other key Ca 2+ -handling proteins, ROS also contribute to cardiac pathology upstream and through indirect mechanisms. In fact, ROS have been suggested to contribute to angiotensin II-induced cardiac hypertrophy by NF-AT translocation, 143 thus participating in excitation-transcription coupling. All the pathological effects of oxidation may involve CaMKII, which is both pro-hypertrophic and pro-arrhythmogenic, 144 and is activated by oxidation. In conjunction with oxidative stress, enhanced SR Ca 2+ leak and elevated phosphorylation-mediated signalling, conspicuous structural remodelling at the levels of TT-SR dyads and/or TT-SR-mitochondria trios has also been reported in the hypertrophied and failing heart. 145, 146 The TT-SR dyadic remodelling, accompanied by changes in the structural proteins such as junctophilin, has been confirmed in various HF models, 147 -149 resulting in orphaned RyRs and dyssynchronous Ca 2+ sparks during EC coupling. 149 These functional changes lead to eroded safety margin of EC coupling 147 or overtly defective local EC coupling and increased propensity for arrhythmogenic Ca 2+ release. 148, 149 Future investigations are warranted to unravel how such dyadic remodelling affects local production of signalling ROS (X-ROS and superoxide flashes), overall ROS homoeostasis (constitutive ROS production), and ROS stability (i.e. RIRR and ROS oscillations), and vice versa.
Perspectives
As one of the most exciting developments in cardiac signalling, recent advances show that ROS as well as RNS modulate microdomain and global [Ca 2+ ] i transients under physiological, stressful, and pathophysiological conditions. The excitement is four-fold. First, the realization that virtually all the molecular players of EC coupling and Ca
2+
handling are authentic or potential effectors of ROS/RNS signalling. Secondly, the visualization of dynamic, regulatory, and local signalling ROS with their microdomains encompassing the dyads. These include mitochondrial superoxide flashes with regulatory mechanisms distinctly different from that for constitutive, homoeostatic ROS generated as byproducts of respiration. Moreover, mechanical stretch triggers X-ROS from the dedicated ROS-generator NOX2 in TTs as well as RNS from eNOS in cardiomyocytes. Thirdly, the demonstrated roles of physiological signalling ROS/RNS in modulating dyadic Ca 2+ signalling events-Ca 2+ sparks. Fourthly, the increasing appreciation of similarities and distinctions between ROS and Ca 2+ signalling in terms of the underlying design principles. With these, it is safe to conclude that ROS signalling adds a new layer of regulation of cardiac EC coupling, in addition to the classic phosphorylation mechanism mediated by kinases and phosphatases. Although powerful, ROS signalling appears to operate with great stability, such that local ROS are promptly terminated and spatially well-confined. However, when cardiomyocytes are challenged with extreme stressors, inter-mitochondrial RIRR takes place and gives rise to hierarchical spatiotemporal ROS dynamics, revealing intrinsic instability of the ROS signalling system. Dysfunctional and instable ROS signalling, in turn, causes dysfunction and instability of Ca 2+ signalling. In fact, oxidative stress has never been so intimately intertwined with Ca 2+ overload and dysregulation. Combined with deranged phosphorylation-mediated signalling, 150, 151 it leads to compromised contractility and exaggerated arrhythmogenicity.
With a large array of interconvertible molecular players, dozens of possible redox-dependent target protein modifications, and only a few specific target sites amidst at least 10-fold more 'non-specific' ones on a given target protein, the ROS signalling is notoriously complex-apparently much more complex than the Ca 2+ signalling that we know. As a rule of thumb, ROS effects are multiphasic and bidirectional, depending on the species of oxidants, their concentrations, history of exposure, and cellular context. By analogy to Ca 2+ signalling, however, we hold the strong belief that under the surface of apparent complexity, there is simplicity at the heart, awaiting elucidation by future investigations. Mastery of the underlying design principles will not only deepen our understanding on how ROS are harnessed to play signalling roles, but also give us the ability to constrain deleterious ROS effects. For instance, rather than the proven failure of indiscriminate scavenging of 'good' and 'bad' ROS, 152 targeted antioxidant therapy could be developed based on precise knowledge of the offending ROS species, compartments, concentrations, and modes of action. Towards that goal, the chasm of insufficient knowledge remains wide and deep, signifying tremendous opportunities for future endeavours.
